Beranda › Karsinoma Sel Skuamosa
Uji klinis Karsinoma Sel Skuamosa yang merekrut di AS
50 studi untuk Karsinoma Sel Skuamosa merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Pittsburgh, PA10 studi
- Los Angeles, CA8 studi
- Boston, MA8 studi
- Houston, TX7 studi
- Nashville, TN7 studi
- New York City, NY7 studi
- Atlanta, GA5 studi
- Durham, NC4 studi
- Tampa, FL4 studi
- Washington, DC4 studi
- Orlando, FL4 studi
- Arlington, VA4 studi
- Queens, NY4 studi
- Rochester, NY3 studi
- Indianapolis, IN3 studi
- Dallas, TX3 studi
- Staten Island, NY3 studi
- San Diego, CA3 studi
- Philadelphia, PA3 studi
- Baltimore, MD3 studi
- Charleston, SC3 studi
- Chicago, IL3 studi
- St. Louis, MO3 studi
Berdasarkan negara bagian
- California12 studi
- Florida11 studi
- Georgia5 studi
- Illinois4 studi
- Indiana3 studi
- Maryland4 studi
- Massachusetts8 studi
- Missouri3 studi
- New York15 studi
- North Carolina5 studi
- Ohio5 studi
- Pennsylvania13 studi
- South Carolina4 studi
- Tennessee7 studi
- Texas11 studi
- Virginia6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Menerima pesertaFase 3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04892173Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06736379Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05027633Effects of Infusion Timing on Treatment Response in Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07630168Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07513389A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06561685A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07602842Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT04915183T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 2
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT02133196Toripalimab With Chemotherapy for Sinus Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT06940180Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07682831Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07773688A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07115043Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07241585A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05859074Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT02507141Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06819228Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07628634Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT05388773Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06615635PDT For Induction Therapy For Head And Neck Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT07214987Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.